Global Genomics Personalized Health Market: By Technology (NGS platforms, RT-PCR, Microarray, and Genetic Analyzers); End Users (Research and Diagnostic centers, Academics, and Others); Test Type (Oncology Testing, Infectious Disease Testing, Genetic Disease Testing, Autoimmune Disease Testing, and Others); Region—Market Forecast and Analysis for 2023–2031
Global genomics personalized health market was valued at US$ 14.9 billion in 2022 and is projected to attain a valuation of US$ 44.4 billion by 2031 at a CAGR of 14.6% during the forecast period 2023–2031. Read More
We Are Trusted By These Great Companies!
Published On: 08-Jun-2023 | Format: | Report ID: AA0623453